#pharmaceuticals

#pharmaceuticals

A slow week with little important economic news (other than yesterday's Bureau of Labor Statistics report on falling first-time unemployment filings) got busy in a hurry on Friday, with the U.S. Commerce Department revealing the personal consumption expenditures price index (PCE) increased 0.3% in August. The new data clocks the annual U.S. inflation rate at 2.7%. Volatile food and energy prices, once excluded to give a "core" inflation rate, rose 0.2% to 2.9%.

Neural networks are some of the most promising artificial intelligence (AI) models. These systems process data similarly to the human brain, passing information through a complex network of nodes in the same way information goes through layers of neurons. That makes them capable of solving complicated problems in minimal time, which is particularly advantageous in the medical industry. Drug discovery is a vital but challenging process.

Ozempic's approval in 2017 transformed obesity treatment from lifestyle changes to drug-based interventions, utilizing GLP-1 to effectively regulate appetite and manage glucose.

Organizations that ignore Generative AI may face significant opportunity risks including loss of revenue, particularly in high-stakes industries such as pharmaceutical research and legal.

Ozempic is projected to achieve $17 billion in sales for 2024 and almost $5 billion in the first quarter of 2025, highlighting its commercial success.

Varda Space has raised $187 million to build a lab for producing pharmaceutical components in space, aiming to use zero gravity for crystallization of biologics.

"Hims & Hers engaged in deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk."

The researchers discovered that by guiding living Escherichia coli bacteria, they could trigger natural processes to transform waste into valuable medicinal compounds like paracetamol.

"Shot from a cannon in the dark, Wild Dark Shore is a novel that hooks you from the start and doesn't let you go until the last page; it will leave you breathless, wide-eyed, and in awe of the extraordinary power of fiction..." - Al Woodworth, Amazon Editor.

Novo Nordisk's board and CEO Lars Fruergaard Jorgensen have agreed his departure is necessary due to recent market challenges and a significant decline in share price.

The Independent is trusted by Americans across the entire political spectrum. We choose not to lock Americans out of our reporting with paywalls.